Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pyrazinamide 500mg tablets
0501090N0AACJCJ
|
Pyrazinamide | Pyrazinamide | Infections | 12 |
|
Pyrazinamide 500mg/5ml oral liquid
0501090N0AABBBB
|
Pyrazinamide | Pyrazinamide | Infections | 2 |
|
Pyrazinamide 1.25g/5ml oral liquid
0501090N0AACHCH
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 1.4g/5ml oral liquid
0501090N0AACECE
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 1.5g/5ml oral liquid
0501090N0AABMBM
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 100mg/5ml oral liquid
0501090N0AABIBI
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 105mg/5ml oral liquid
0501090N0AACFCF
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 125mg/5ml oral liquid
0501090N0AABHBH
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 150mg/5ml oral liquid
0501090N0AABABA
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 175mg/5ml oral liquid
0501090N0AAA7A7
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 1g/5ml oral liquid
0501090N0AABCBC
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 200mg/5ml oral liquid
0501090N0AABFBF
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 250mg/5ml oral liquid
0501090N0AABKBK
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 275mg/5ml oral liquid
0501090N0AABUBU
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 300mg/5ml oral liquid
0501090N0AABJBJ
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 312.5mg/5ml oral liquid
0501090N0AACDCD
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 350mg/5ml oral liquid
0501090N0AABEBE
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 375mg/5ml oral liquid
0501090N0AABDBD
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 400mg/5ml oral liquid
0501090N0AABTBT
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 420mg/5ml oral liquid
0501090N0AABZBZ
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 425mg/5ml oral liquid
0501090N0AABRBR
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 430mg/5ml oral liquid
0501090N0AACBCB
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 450mg/5ml oral liquid
0501090N0AABGBG
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 490mg/5ml oral liquid
0501090N0AABVBV
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 50mg/5ml oral liquid
0501090N0AAA9A9
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.